Hormonal therapy use associated with later glaucoma diagnosis in postmenopausal women

Hormonal therapy may delay glaucoma onset in postmenopausal women, with longer duration of treatment linked to later diagnosis of glaucoma, according to a study in Investigative Ophthalmology & Vision Science.
“Our previous case-only study found that the age of menopause was the most significant predictor for the diagnosis of glaucoma,” the study authors wrote. “Here, we aim to examine the association between [hormonal therapy] and the onset of glaucoma in a case-only population.”
In a retrospective study of female veterans with open-angle glaucoma, researchers used